CLDX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 120620 min ago

@ $36.11

Wydano: 14 vas. 2024 @ 20:49

Zwrot: 16.91%

Poprzedni sygnał: vas. 13 - 19:40

Poprzedni sygnał: Sprzedaż

Zwrot: 0.46 %

Live Chart Being Loaded With Signals

Commentary (7 geg. 2024 @ 23:00):

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases...

Stats
Dzisiejszy wolumen	900 316
Średni wolumen	932 296
Kapitalizacja rynkowa	2.78B
EPS	$0 ( 2024-05-02 )
Następna data zysków	( $-0.690 ) 2024-06-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-14.46
ATR14	$0.0830 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-13	Jimenez Freddy A.	Buy	20 000	Common Stock
2024-02-13	Jimenez Freddy A.	Buy	4 166	Common Stock
2024-02-13	Jimenez Freddy A.	Sell	4 166	Incentive Stock Option (Right to Buy)
2024-02-13	Jimenez Freddy A.	Sell	20 000	Incentive Stock Option (Right to Buy)
2024-01-02	Martin Samuel Bates	Buy	10 750	Common Stock

INSIDER POWER
75.37
Last 97 transactions
Buy: 2 900 849 \| Sell: 507 801

Wolumen Korelacja

Długi: 0.24 (neutral)

Krótki: -0.01 (neutral)

Signal:(34.675) Neutral

Celldex Therapeutics Inc Korelacja

10 Najbardziej pozytywne korelacje
NSTS	0.918
BOKF	0.917
FNWD	0.917
GCBC	0.916
NECB	0.913
UMBF	0.913
MSBI	0.91
HMNF	0.909
AHPI	0.907
FSBC	0.906

10 Najbardziej negatywne korelacje
CHMA	-0.906
VTIP	-0.906
DSPG	-0.895
SUMO	-0.893
SOPH	-0.887
SMED	-0.882
OSMT	-0.878
NVCN	-0.876
MNTV	-0.876
DVCR	-0.872

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Celldex Therapeutics Inc Korelacja - Waluta/Towar

0.57
( weak )

0.70
( moderate )

0.00
( neutral )

0.13
( neutral )

0.76
( moderate )

-0.69
( moderate negative )

Celldex Therapeutics Inc Finanse

Annual	2023
Przychody:	$6.88M
Zysk brutto:	$3.88M (56.30 %)
EPS:	$-2.92

FY	2023
Przychody:	$6.88M
Zysk brutto:	$3.88M (56.30 %)
EPS:	$-2.92

FY	2022
Przychody:	$2.36M
Zysk brutto:	$957 000 (40.60 %)
EPS:	$-2.62

FY	2021
Przychody:	$4.65M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-1.640

Financial Reports:

No articles found.

Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity; CDX-1140, a human agonist monoclonal antibody targeted to CD40, a key activator of immune response, which is found on dendritic cells, macrophages, and B cells, as well as is expressed on various cancer cells; and CDX-527, a bispecific antibody, which uses the company's proprietary active anti-PD-L1 and CD27 human antibodies to couple CD27 costimulation with blockade of the PD-L1/PD-1 pathway to help prime and activate anti-tumor T cell responses through CD27 costimulation. The company has research collaboration and license agreements with University of Southampton to develop human antibodies towards CD27; Amgen Inc. with exclusive rights to CDX-301 and CD40 ligand; and Yale University. Celldex Therapeutics, Inc. was incorporated in 1983 and is headquartered in Hampton, New Jersey.